Status:

RECRUITING

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Postoperative Pain

Eligibility:

FEMALE

18-65 years

Phase:

PHASE2

Brief Summary

This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain fol...

Detailed Description

152 women will be randomized into one of two arms; participants in the first arm (Intervention) will receive oxytocin infusion, 30 IU in 500 ml IV infusion at a rate of 5 IU/h (83.33 ml/h), the second...

Eligibility Criteria

Inclusion

  • Ages 18-65 years old
  • ASA category 1-3
  • Scheduled to undergo minimally invasive hysterectomy
  • No documented allergy to oxytocin

Exclusion

  • American Society of Anesthesiologists (ASA) group 4 or greater
  • Age \>65 years old
  • Additional surgical procedures including but not limited to minor laparotomy, omentectomy, cystectomy, vaginectomy, and/or ablation of endometriosis.
  • Active opioid prescription of the equivalent of oxycodone \>10 mg /day
  • Opioid use disorder, including patients in treatment receiving naltrexone or Suboxone (Buprenorphine-naloxone)
  • Allergies to any study medication: acetaminophen, celecoxib, ketorolac, fentanyl, hydromorphone, or oxycodone.
  • Epidural/Regional anesthesia for intra-operative or post-operative pain.
  • Inability to understand the questionnaires
  • Intra-operative and post-operative exclusion: Procedure converted to open or extension of primary surgery, Intra-operative EBL \>500 ml., Placement of epidural catheter or regional anesthesia at PACU for pain management, Hospitalization of the patient due to surgical or anesthetic complications

Key Trial Info

Start Date :

June 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

152 Patients enrolled

Trial Details

Trial ID

NCT06483659

Start Date

June 1 2025

End Date

December 1 2026

Last Update

December 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02215

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy | DecenTrialz